(HealthDay)—Brintellix (vortioxetine) has been approved by the U.S. Food and Drug Administration to treat adults with major depressive disorder, often referred to as depression.
The disorder may have symptoms including lack of interest in usual activities, weight or appetite changes, sleep problems, feelings of guilt or worthlessness, lack of concentration and thoughts of suicide.
In seven clinical studies, Brintellix proved effective in treating depression and in preventing future episodes, the FDA said in a news release. The most common side effects observed included nausea, constipation and vomiting.
Brintellix has a boxed label warning that antidepressants can raise the risk of suicidal thoughts among some users, especially among children, adolescents and adults aged 18 to 24. Doctors should carefully monitor users of Brintellix and similar drugs, especially during initial treatment, the FDA advised.
Brintellix is marketed by Takeda Pharmaceuticals and Lunbeck, both based in Deerfield, Ill.
Explore further: First non-hormonal remedy approved for menopausal hot flashes
More information: The U.S. National Institute of Mental Health has more about depression.
Copyright © 2013 HealthDay. All rights reserved.
Medical Xpress on facebook
Related Stories
First generic lexapro approved
Mar 14, 2012
(HealthDay) -- The Israeli drug maker Teva Pharmaceuticals has gained the first U.S. approval to market generic Lexapro (escitalopram) to treat depression and general anxiety disorder, the U.S. Food and Drug Administration ...
First non-hormonal remedy approved for menopausal hot flashes
Jul 01, 2013
(HealthDay)—Brisdelle (paroxetine) has been approved by the U.S. Food and Drug Administration as the first non-hormonal treatment to treat hot flashes associated with menopause.
Iclusig approved for rare leukemias
Dec 16, 2012
(HealthDay)—Iclusig (ponatinib) has been approved by the U.S. Food and Drug Administration to treat two rare forms of leukemia..
Antidepressant-suicide link in youths absent in new analysis
Feb 06, 2012
In 2004, concerns about antidepressant drugs increasing suicidal thoughts and behaviors in young patients prompted the FDA to issue a rare "black box warning." Now, a new analysis of clinical trial data finds that treatment ...
Stivarga approved for advanced colorectal cancer
Sep 27, 2012
(HealthDay)—Stivarga (regorafenib) has been approved by the U.S. Food and Drug Administration to treat colorectal cancer that has spread despite prior treatment.
Recommended for you
Over-the counter as effective as Rx at managing post-tonsillectomy pain
1 minute ago
You may be able to eat all of the ice cream you want after having your tonsils removed, but researchers at Henry Ford Hospital in Detroit say you don't necessarily need a prescription to reduce post-operative pain—an over-the-counter ...
Statin medications may prevent dementia and memory loss with longer use
50 minutes ago
A review of dozens of studies on the use of statin medications to prevent heart attacks shows that the commonly prescribed drugs pose no threat to short-term memory, and that they may even protect against dementia when taken ...
Roche 'extremely open' to talks with Novartis: report
4 hours ago
The head of Swiss pharmaceutical giant Roche is open to renewed cooperation with competitor Novartis, he told the Financial Times in an interview published Tuesday.
Doctors: US execution plan jeopardizing hospitals
21 hours ago
Hundreds of anesthesiologists urged the state of Missouri on Monday not to use propofol in an upcoming execution, saying the fallout could jeopardize the availability of the anesthetic relied on by thousands of U.S. hospitals ...
FDA adds most severe warning to Pfizer's Tygacil
Sep 30, 2013
Regulators are putting their harshest warning on Pfizer's antibiotic Tygacil, saying the drug is associated with an increased risk of death.
FDA approves first pre-surgical breast cancer drug
Sep 30, 2013
Federal health officials say they have approved a biotech drug from Roche as the first medicine labeled for the treatment of breast cancer before surgery.
User comments
© Medical Xpress 2011-2013, Phys.org network
(HealthDay)—Brintellix (vortioxetine) has been approved by the U.S. Food and Drug Administration to treat adults with major depressive disorder, often referred to as depression.
The disorder may have symptoms including lack of interest in usual activities, weight or appetite changes, sleep problems, feelings of guilt or worthlessness, lack of concentration and thoughts of suicide.
In seven clinical studies, Brintellix proved effective in treating depression and in preventing future episodes, the FDA said in a news release. The most common side effects observed included nausea, constipation and vomiting.
Brintellix has a boxed label warning that antidepressants can raise the risk of suicidal thoughts among some users, especially among children, adolescents and adults aged 18 to 24. Doctors should carefully monitor users of Brintellix and similar drugs, especially during initial treatment, the FDA advised.
Brintellix is marketed by Takeda Pharmaceuticals and Lunbeck, both based in Deerfield, Ill.
Explore further: First non-hormonal remedy approved for menopausal hot flashes
More information: The U.S. National Institute of Mental Health has more about depression.
Copyright © 2013 HealthDay. All rights reserved.
Medical Xpress on facebook
Related Stories
First generic lexapro approved
Mar 14, 2012
(HealthDay) -- The Israeli drug maker Teva Pharmaceuticals has gained the first U.S. approval to market generic Lexapro (escitalopram) to treat depression and general anxiety disorder, the U.S. Food and Drug Administration ...
First non-hormonal remedy approved for menopausal hot flashes
Jul 01, 2013
(HealthDay)—Brisdelle (paroxetine) has been approved by the U.S. Food and Drug Administration as the first non-hormonal treatment to treat hot flashes associated with menopause.
Iclusig approved for rare leukemias
Dec 16, 2012
(HealthDay)—Iclusig (ponatinib) has been approved by the U.S. Food and Drug Administration to treat two rare forms of leukemia..
Antidepressant-suicide link in youths absent in new analysis
Feb 06, 2012
In 2004, concerns about antidepressant drugs increasing suicidal thoughts and behaviors in young patients prompted the FDA to issue a rare "black box warning." Now, a new analysis of clinical trial data finds that treatment ...
Stivarga approved for advanced colorectal cancer
Sep 27, 2012
(HealthDay)—Stivarga (regorafenib) has been approved by the U.S. Food and Drug Administration to treat colorectal cancer that has spread despite prior treatment.
Recommended for you
Over-the counter as effective as Rx at managing post-tonsillectomy pain
1 minute ago
You may be able to eat all of the ice cream you want after having your tonsils removed, but researchers at Henry Ford Hospital in Detroit say you don't necessarily need a prescription to reduce post-operative pain—an over-the-counter ...
Statin medications may prevent dementia and memory loss with longer use
50 minutes ago
A review of dozens of studies on the use of statin medications to prevent heart attacks shows that the commonly prescribed drugs pose no threat to short-term memory, and that they may even protect against dementia when taken ...
Roche 'extremely open' to talks with Novartis: report
4 hours ago
The head of Swiss pharmaceutical giant Roche is open to renewed cooperation with competitor Novartis, he told the Financial Times in an interview published Tuesday.
Doctors: US execution plan jeopardizing hospitals
21 hours ago
Hundreds of anesthesiologists urged the state of Missouri on Monday not to use propofol in an upcoming execution, saying the fallout could jeopardize the availability of the anesthetic relied on by thousands of U.S. hospitals ...
FDA adds most severe warning to Pfizer's Tygacil
Sep 30, 2013
Regulators are putting their harshest warning on Pfizer's antibiotic Tygacil, saying the drug is associated with an increased risk of death.
FDA approves first pre-surgical breast cancer drug
Sep 30, 2013
Federal health officials say they have approved a biotech drug from Roche as the first medicine labeled for the treatment of breast cancer before surgery.
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment